Publication | Closed Access

Repurposing mosloflavone/5,6,7-trimethoxyflavone-resveratrol hybrids: Discovery of novel p38-α MAPK inhibitors as potent interceptors of macrophage-dependent production of proinflammatory mediators

InflammationMolecular PharmacologyMedicinal ChemistryMacrophage-dependent ProductionAnti-inflammatoryMedicineImmunologyProinflammatory MediatorsMosloflavone/5,6,7-trimethoxyflavone-resveratrol HybridsAnti-cancer AgentPharmacologyCell BiologyDrug Discovery